Vivos Therapeutics (VVOS) Q3 2025 Earnings

19AugConfirmed
Q3 2024
Q4 2024
Q2 2025
Q3 2025
-1.05
-0.83
-0.6
-0.38

Details

Expected EPS
-0.38
Actual EPS
-0.55
Surprise EPS
-0.17
Surprise Percent
+44.74%

Description

Vivos Therapeutics (VVOS) has reported earnings of -0.55 per share for Q3 2025.

0 Comments

Share your thoughts